Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNγ and IL-4 are involved

Gastroenterology

Volumn 130, Issue 2, 2006, Pages 373-388

  Chinen, Takatoshi ^a,b   Kobayashi, Takashi ^a   Ogata, Hisanobu ^a   Takaesu, Giichi ^a   Takaki, Hiromi ^a   Hashimoto, Masayuki ^a   Yagita, Hideo ^c   Nawata, Hajime ^b   Yoshimura, Akihiko ^a,d  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; LIPOPOLYSACCHARIDE; SUPPRESSOR OF CYTOKINE SIGNALING 1; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; COLON MUCOSA; CONTROLLED STUDY; CROSS BREEDING; DISEASE EXACERBATION; DISEASE SEVERITY; EMBRYO; ENTERITIS; EPITHELIUM CELL; FEMALE; GENE TARGETING; INFLAMMATION; KNOCKOUT MOUSE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 32044451547     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.10.051     Document Type: Article

References (59)

1. W. Strober, I.J. Fuss, R.S. Blumberg The immunology of mucosal models of inflammation Annu Rev Immunol 20 2002 495 549
2. G. Bouma, W. Strober The immunological and genetic basis of inflammatory bowel disease Nat Rev Immunol 3 2003 521 533
3. L. Camoglio, A.A. Te Velde, A.J. Tigges, P.K. Das, S.J. Van Deventer Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease Inflamm Bowel Dis 4 1998 285 290
4. Y. Tsukada, T. Nakamura, M. Iimura, B.E. Iizuka, N. Hayashi Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis Am J Gastroenterol 97 2002 2820 2828
5. P. Desreumaux, E. Brandt, L. Gambiez, D. Emilie, K. Geboes, O. Klein, N. Ectors, A. Cortot, M. Capron, J.F. Colombel Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease Gastroenterology 113 1997 118 126
6. S. Dubucquoi, A. Janin, O. Klein, P. Desreumaux, P. Quandalle, A. Cortot, M. Capron, J.F. Colombel Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease Gut 37 1995 242 246
7. A.D. Christ, A.C. Stevens, H. Koeppen, S. Walsh, F. Omata, O. Devergne, M. Birkenbach, R.S. Blumberg An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease Gastroenterology 115 1998 307 313
8. S. Schreiber, P. Rosenstiel, J. Hampe, S. Nikolaus, B. Groessner, A. Schottelius, T. Kuhbacher, J. Hamling, U.R. Folsch, D. Seegert Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease Gut 51 2002 379 385
9. K. Shuai, B. Liu Regulation of JAK-STAT signalling in the immune system Nat Rev Immunol 3 2003 900 911
10. C.V. Ramana, M.P. Gil, R.D. Schreiber, G.R. Stark Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling Trends Immunol 23 2002 96 101
11. C. Blanchard, S. Durual, M. Estienne, S. Emami, S. Vasseur, J.C. Cuber Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6 Int J Biochem Cell Biol 37 2005 2559 2573
12. T. Hanada, I. Kinjyo, K. Inagaki-Ohara, A. Yoshimura Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases Rev Physiol Biochem Pharmacol 149 2003 72 86
13. A. Suzuki, T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, T. Hoshino, M. Kubo, A. Yamashita, M. Okabe, K. Takeda, S. Akira, S. Matsumoto, A. Toyonaga, M. Sata, A. Yoshimura CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation J Exp Med 193 2001 471 481
14. N.C. Tebbutt, A.S. Giraud, M. Inglese, B. Jenkins, P. Waring, F.J. Clay, S. Malki, B.M. Alderman, D. Grail, F. Hollande, J.K. Heath, M. Ernst Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice Nat Med 8 2002 1089 1097
15. T. Kuhbacher, P. Gionchetti, J. Hampe, U. Helwig, P. Rosenstiel, M. Campieri, H.J. Buhr, S. Schreiber Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis Clin Exp Immunol 123 2001 395 401
16. P. Mombaerts, E. Mizoguchi, M.J. Grusby, L.H. Glimcher, A.K. Bhan, S. Tonegawa Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice Cell 75 1993 274 282
17. J.C. Marine, D.J. Topham, C. McKay, D. Wang, E. Parganas, D. Stravopodis, A. Yoshimura, J.N. Ihle SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality Cell 98 1999 609 616
18. H. Yagita, K. Takeda, Y. Hayakawa, M.J. Smyth, K. Okumura TRAIL and its receptors as targets for cancer therapy Cancer Sci 95 2004 777 783
19. Y. Okuda, I. Takahashi, J.K. Kim, N. Ohta, K. Iwatani, H. Iijima, Y. Kai, H. Tamagawa, T. Hiroi, M.N. Kweon, S. Kawano, K. Takeda, S. Akira, Y. Sasaki, M. Hori, H. Kiyono Development of colitis in signal transducers and activators of transcription 6-deficient T-cell receptor alpha-deficient mice a potential role of signal transducers and activators of transcription 6-independent interleukin-4 signaling for the generation of Th2-biased pathological CD4+ betabetaT cells Am J Pathol 162 2003 263 271
20. K. Inagaki-Ohara, T. Chinen, G. Matsuzaki, A. Sasaki, Y. Sakamoto, K. Hiromatsu, F. Nakamura-Uchiyama, Y. Nawa, A. Yoshimura Mucosal T cells bearing TCRgammadelta play a protective role in intestinal inflammation J Immunol 173 2004 1390 1398
21. C. Booth, S. Patel, G.R. Bennion, C.S. Potten The isolation and culture of adult mouse colonic epithelium Epithelial Cell Biol 4 1995 76 86
22. A. Sasaki, T. Taketomi, T. Wakioka, R. Kato, A. Yoshimura Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation J Biol Chem 276 2001 36804 36808
23. C.J. Greenhalgh, M.E. Miller, D.J. Hilton, P.K. Lund Suppressors of cytokine signaling relevance to gastrointestinal function and disease Gastroenterology 123 2002 2064 2081
24. T. Hanada, H. Yoshida, S. Kato, K. Tanaka, K. Masutani, J. Tsukada, Y. Nomura, H. Mimata, M. Kubo, A. Yoshimura Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity Immunity 19 2003 437 450
25. A. Mizoguchi, E. Mizoguchi, C. Chiba, G.M. Spiekermann, S. Tonegawa, C. Nagler-Anderson, A.K. Bhan Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease J Exp Med 183 1996 847 856
26. I. Takahashi, H. Kiyono, S. Hamada CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice Gastroenterology 112 1997 1876 1886
27. P. Lovato, C. Brender, J. Agnholt, J. Kelsen, K. Kaltoft, A. Svejgaard, K.W. Eriksen, A. Woetmann, N. Odum Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease J Biol Chem 278 2003 16777 16781
28. J. Mudter, B. Weigmann, B. Bartsch, R. Kiesslich, D. Strand, P.R. Galle, H.A. Lehr, J. Schmidt, M.F. Neurath Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases Am J Gastroenterol 100 2005 64 72
29. M.F. Neurath, I. Fuss, G. Schurmann, S. Pettersson, K. Arnold, H. Muller-Lobeck, W. Strober, C. Herfarth, K.H. Buschenfelde Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease Ann N Y Acad Sci 859 1998 149 159
30. A. Mizoguchi, E. Mizoguchi, A.K. Bhan The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice Gastroenterology 116 1999 320 326
31. S.R. Targan Biology of inflammation in Crohn's disease mechanisms of action of anti-TNF-a therapy Can J Gastroenterol 14 Suppl C 2000 13C 16C
32. L. Dianda, A.M. Hanby, N.A. Wright, A. Sebesteny, A.C. Hayday, M.J. Owen T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment Am J Pathol 150 1997 91 97
33. L. Biancone, G. Monteleone, R. Marasco, F. Pallone Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives Clin Exp Immunol 113 1998 198 205
34. K. Kett, T.O. Rognum, P. Brandtzaeg Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon Gastroenterology 93 1987 919 924
35. I.J. Fuss, M. Neurath, M. Boirivant, J.S. Klein, C. de la Motte, S.A. Strong, C. Fiocchi, W. Strober Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1996 1261 1270
36. F. Heller, P. Florian, C. Bojarski, J. Richter, M. Christ, B. Hillenbrand, J. Mankertz, A.H. Gitter, N. Burgel, M. Fromm, M. Zeitz, I. Fuss, W. Strober, J.D. Schulzke Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology 129 2005 550 564
37. M. Boirivant, I.J. Fuss, A. Chu, W. Strober Oxazolone colitis a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J Exp Med 188 1998 1929 1939
38. G. D'Haens Infliximab for ulcerative colitis finally some answers Gastroenterology 128 2005 2161 2164
39. W.E. Paul Interleukin-4 a prototypic immunoregulatory lymphokine Blood 77 1991 1859 1870
40. T. Naka, H. Tsutsui, M. Fujimoto, Y. Kawazoe, H. Kohzaki, Y. Morita, R. Nakagawa, M. Narazaki, K. Adachi, T. Yoshimoto, K. Nakanishi, T. Kishimoto SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo Immunity 14 2001 535 545
41. C.E. Egwuagu, C.R. Yu, M. Zhang, R.M. Mahdi, S.J. Kim, I. Gery Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells implications for Th cell lineage commitment and maintenance J Immunol 168 2002 3181 3187
42. I. Kinjyo, T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, A. Yoshimura SOCS1/JAB is a negative regulator of LPS-induced macrophage activation Immunity 17 2002 583 591
43. S. Kamizono, T. Hanada, H. Yasukawa, S. Minoguchi, R. Kato, M. Minoguchi, K. Hattori, S. Hatakeyama, M. Yada, S. Morita, T. Kitamura, H. Kato, K. Nakayama, A. Yoshimura The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2 J Biol Chem 276 2001 12530 12538
44. T. Hanada, T. Yoshida, I. Kinjyo, S. Minoguchi, H. Yasukawa, S. Kato, H. Mimata, Y. Nomura, Y. Seki, M. Kubo, A. Yoshimura A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box J Biol Chem 276 2001 40746 40754
45. X.P. Chen, J.A. Losman, S. Cowan, E. Donahue, S. Fay, B.Q. Vuong, M.C. Nawijn, D. Capece, V.L. Cohan, P. Rothman Pim serine/threonine kinases regulate the stability of Socs-1 protein Proc Natl Acad Sci U S A 99 2002 2175 2180
46. G. Schluter, D. Boinska, S.C. Nieman-Seyde Evidence for translational repression of the SOCS-1 major open reading frame by an upstream open reading frame Biochem Biophys Res Commun 268 2000 255 261
47. T. Yoshida, H. Ogata, M. Kamio, A. Joo, H. Shiraishi, Y. Tokunaga, M. Sata, H. Nagai, A. Yoshimura SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis J Exp Med 199 2004 1701 1707
48. F. Heller, I.J. Fuss, E.E. Nieuwenhuis, R.S. Blumberg, W. Strober Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells Immunity 17 2002 629 638
49. D.J. Conrad, M. Lu Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription Am J Respir Cell Mol Biol 22 2000 226 234
50. P.J. Ceponis, F. Botelho, C.D. Richards, D.M. McKay Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement J Biol Chem 275 2000 29132 29137
51. L.A. Dieleman, A. Arends, S.L. Tonkonogy, M.S. Goerres, D.W. Craft, W. Grenther, R.K. Sellon, E. Balish, R.B. Sartor Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice Infect Immun 68 2000 5107 5113
52. M. Kobayashi, M.N. Kweon, H. Kuwata, R.D. Schreiber, H. Kiyono, K. Takeda, S. Akira Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice J Clin Invest 111 2003 1297 1308
53. M.M. Chong, D. Metcalf, E. Jamieson, W.S. Alexander, T.W. Kay Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation Blood 106 2005 1668 1675
54. A. Ryo, F. Suizu, Y. Yoshida, K. Perrem, Y.C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, K.P. Lu Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA Mol Cell 12 2003 1413 1426
55. G. Jarnerot, E. Hertervig, I. Friis-Liby, L. Blomquist, P. Karlen, C. Granno, M. Vilien, M. Strom, A. Danielsson, H. Verbaan, P.M. Hellstrom, A. Magnuson, B. Curman Infliximab as rescue therapy in severe to moderately severe ulcerative colitis a randomized, placebo-controlled study Gastroenterology 128 2005 1805 1811
56. M.F. Neurath, I. Fuss, M. Pasparakis, L. Alexopoulou, S. Haralambous, K.H. Meyer zum Buschenfelde, W. Strober, G. Kollias Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice Eur J Immunol 27 1997 1743 1750
57. J.M. Van den Brande, H. Braat, G.R. van den Brink, H.H. Versteeg, C.A. Bauer, I. Hoedemaeker, C. van Montfrans, D.W. Hommes, M.P. Peppelenbosch, S.J. van Deventer Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease Gastroenterology 124 2003 1774 1785
58. W.J. Sandborn, S.B. Hanauer, S. Katz, M. Safdi, D.G. Wolf, R.D. Baerg, W.J. Tremaine, T. Johnson, N.N. Diehl, A.R. Zinsmeister Etanercept for active Crohn's disease a randomized, double-blind, placebo-controlled trial Gastroenterology 121 2001 1088 1094
59. A. Lugering, M. Schmidt, N. Lugering, H.G. Pauels, W. Domschke, T. Kucharzik Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway Gastroenterology 121 2001 1145 1157